期刊文献+

他汀类药物非调脂作用机制的研究进展 被引量:3

原文传递
导出
摘要 他汀类药物除了其调脂主导作用外,近期研究发现还具有不依赖于其降血脂特性的非调脂抗动脉粥样硬化作用如抑制血管平滑肌细咆增殖与迁移、改善内皮功能、抗炎症反应和稳定斑块等多向性效应。本文对他汀类药物非调脂作用机制的最新研究进展作一综述。
出处 《国外医学(老年医学分册)》 2002年第5期214-218,共5页 Foreign Medical Sciences(Geriatrics)
  • 相关文献

参考文献24

  • 1[1]Bellosta S,Ferri N,Arnaboldi L et al.Pleiotropic effects of statins in atherosclerosis and diabetes.Diabetes Care,2000;23(Suppl 2B):72~78
  • 2[2]Axel DI,Riessen R,Runge H et al.Effects of cerivastatin on human arterial smooth muscle cell proliferation and migration in transfilter cocultures.J Cardiovasc Pharmacol,2000;35(4):619~629
  • 3[3]Kreuzer J,Watson L,Herdegen T et al.Effects of HMG-CoA reductase inhibition on PDGF-and angiotensin Ⅱ-mediated signal transduction:suppression of c-Jun and c-Fos in human smooth muscle cells in vitro.Eur J Med Res,1999;4(4):135~143
  • 4[4]Tesfamariam B,Frohlich BH,Gregg RE.Differential effects of pravastatin,simvastatin,and atorvastatin on Ca2+ release and vascular reactivity.J Cardiovasc Pharmacol,1999;34(1):95~101
  • 5[5]Guijarro C,Blanco-Colio LM,Massy ZA et al.Lipophilic statins induce apoptosis of human vascular smooth muscle cells.Kidney Int Suppl,1999;71:S88~S91
  • 6[6]Knapp AC,Huang J,Starling G et al.Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death.Atherosclerosis,2000;152(1):217~227
  • 7[7]Weiss RH,Ramirez A,Joo A.Short-term pravastatin mediates growth inhibition and apoptosis,independently of Ras,via the signaling proteins p27Kip1 and PI3 kinase.J Am Soc Nephrol,1999;10(9):1880~1890
  • 8任汉云,张念先,徐红,陆道培.胆固醇合成抑制剂辛伐他汀对K562细胞增殖和凋亡的作用[J].中华血液学杂志,2001,22(2):72-75. 被引量:14
  • 9[9]Baller D,Notohamiprodjo G,Gleichmann U et al.Improvement in coronary flow reserve determined by position emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis.Circulation,1999;99:2871~2875
  • 10[10]Dobrucki LW,Kalinowski L,Dobrucki IT,Statin-stimulated nitric oxide release from endothelium.Med Sci Monit,2001;7(4):622~627

二级参考文献10

  • 1Cuthbert JA,Lipsky PE.Regulation of proliferation and ras localization in transformed cells by products of mevalonate metabolism[].Cancer Research.1997
  • 2Carlberg M,Dricu A,Blegan H,et al.Mevalonic acid is limiting for Nlinked glycosylation and translocation of the insulin-like growth factor-I receptor to the cell surface[].Journal of Biological Chemistry.1996
  • 3Daley GQ,van Etten RA,Baltimore D.Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome[].Science.1990
  • 4Iwama A,Sawamura M,Nara Y,et al.Effect of lovastatin and fluromavalonate on phosphatidylinositol 3-kinase activity stimulated with PDGF[].Clinical and Experimental Pharmacology and Physiology.1995
  • 5Dimitroulakos J,Nohynek D,Backway KL,et al.Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: a potential therapeutic approach[].Blood.1999
  • 6Gibbs JB,Oliff A,Kohl NE.Farnesyltransferase inhibitors: ras research yields a potential cancer therapeutic[].Cell.1995
  • 7Lebowitz PF,Sakamura D,Prendergast GC.Farnesyl transferase inhibitors induce apoptosis of Ras-transformed cells denied substratum attachment[].Cancer Research.1997
  • 8Newman A,Clutterbuck RD,Powles RL,et al.Selective inhibition of primary myeloid leukemia cell growth by lovastatin[].Leukemia.1994
  • 9Cortez D,Stoica G,Dierce JH,et al.The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras dependent signaling pathway[].Oncegene.1996
  • 10McGahon A,Bissonnette R,Schmitt M,et al.BCR/ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death[].Blood.1994

共引文献13

同被引文献18

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部